| 1 |
Critchley M. Arteriosclerotic Parkinsonism [J]. Brain, 1929, 52: 23-83.
|
| 2 |
Thompson PD, Marsden CD. Gait disorder of subcortical arteriosclerotic encephalopathy: Binswanger's disease [J]. Mov Disord, 1987, 2(1): 1-8.
|
| 3 |
Demirkiran M, Bozdemir H, Sarica Y. Vascular Parkinsonism: a distinct, heterogeneous clinical entity [J]. Acta Neurol Scand, 2001, 104(2): 63-67.
|
| 4 |
Caslake R, Taylor K, Scott N, et al. Age and gender specific incidence of vascular Parkinsonism, progressive supranuclear palsy, and parkinsonian-type multiple system atrophy in North East Scotland: the PINE study [J]. Parkinsonism Relat Disord, 2014, 20(8): 834-839.
|
| 5 |
Levin OS, Chimagomedova AS, Skripkina NA, et al. Nonmotor symptoms in vascular and other secondary Parkinsonism [J]. Int Rev Neurobiol, 2017, 134: 1303-1344.
|
| 6 |
王丽娟, 张玉虎. 中国血管性帕金森综合征诊断与治疗专家共识 [J]. 全科医学临床与教育, 2017, 15(4): 364-367.
|
| 7 |
Vizcarral JA, Lang AE, Sethi KD, et al. Vascular Parkinsonism: deconstructing a syndrome [J]. Mov Disord, 2015, 30(7): 886-894.
|
| 8 |
Mantese CE, Hainzenreder TB. Neuromelanin accumulation in Substantia nigra in vascular Parkinsonism [J]. J Neural Transm (Vienna), 2020, 127(1): 1089-1091.
|
| 9 |
Korczyn AD. Vascular Parkinsonism-characteristics, pathogenesis and treatment [J]. Nat Rev Neurol, 2015, 11(6): 319-326.
|
| 10 |
De Laat KF, Tuladhar AM, van Norden AG, et al. Loss of white matter integrity is associated with gait disorders in cerebral small vessel disease [J]. Brain, 2011, 134(Pt 1): 73-83.
|
| 11 |
Salsone M, Caligiuri ME, Vescio V, et al. Microstructural changes of normal-appearing white matter in vascular Parkinsonism [J]. Parkinsonism Relat Disord, 2019, 63: 60-65
|
| 12 |
Dunet V, Deverdun J, Charroud C, et al. Cognitive impairment and basal ganglia functional connectivity in vascular Parkinsonism [J]. AJNR Am J Neuroradiol, 2016, 37(12): 2310-2316
|
| 13 |
FitzGerald PM, Jankovic J. Lower body Parkinsonism: evidence for vascular etiology [J]. Mov Disord, 1989, 4(3): 259-260.
|
| 14 |
Factor SA. The clinical spectrum of freezing of gait in atypical Parkinsonism [J]. Mov Disord, 2008, 23 Suppl 2: S431-S438.
|
| 15 |
Gupta D, Kuruvilla A. Vascular Parkinsonism: what makes it different? [J]. Postgrad Med J, 2011, 87(1034): 829-836.
|
| 16 |
Nonnekes J, Goselink RJM, Růžička E, et al. Neurological disorders of gait, balance and posture: a sign-based approach [J]. Nat Rev Neurol, 2018, 14(3): 183-189.
|
| 17 |
Ferreira F, Gago MF, Bicho E, et al. Gait stride-to-stride variability and foot clearance pattern analysis in Idiopathic Parkinson's Disease and vascular Parkinsonism [J]. J Biomech, 2019, 92: 98-104.
|
| 18 |
Ba Okud, Kawabata K, Tachibana H, et al. Primitive reflexes distinguish vascular Parkinsonism from Parkinson's disease [J]. Clin Neurol Neurosurg, 2008, 110(6): 562-565.
|
| 19 |
Vale TC, Barbosa MT, Caramelli P, et al. Vascular Parkinsonism and cognitive impairment: literature review, Brazilian studies and case vignettes [J]. Dement Neuropsychol, 2012, 6(3): 137-144.
|
| 20 |
Colosimo C, Morgante L, Antonini A, et al. Non-motor symptoms in atypical and secondary Parkinsonism: the PRIAMO study [J]. J Neurol, 2010, 257(1): 5-14.
|
| 21 |
Vale TC, Caramelli P, Cardoso F. Clinicoradiological comparison between vascular Parkinsonism and Parkinson's disease [J]. J Neurol Neurosurg Psychiatry, 2015, 86(5): 547-553.
|
| 22 |
Glass PG, Lees AJ, Bacellar A, et al. The clinical features of pathologically confirmed vascular Parkinsonism [J]. J Neurol Neurosurg Psychiatry, 2012, 83(10): 1027-1029.
|
| 23 |
Katzenschlager R, Zijlmans J, Evans A, et al. Olfactory function distinguishes vascular Parkinsonism from Parkinson's disease [J]. J Neurol Neurosurg Psychiatry, 2004, 75(12): 1749-1752.
|
| 24 |
Vale TC, Caramelli P, Cardoso F. Clinicoradiological comparison between vascular Parkinsonism and Parkinson's disease [J]. Neurol Neurosurg Psychiatry, 2014, 86(5): 547-553.
|
| 25 |
Contrafatto D, Mostile G, Nicoletti A, et al. [(123)I]FP-CIT-SPECT asymmetry index to differentiate Parkinson's disease from vascular Parkinsonism [J]. Acta Neurol Scand, 2012, 126(1): 12-16.
|
| 26 |
Antonini A, Vitale C, Barone P, et al. The relationship between cerebral vascular disease and Parkinsonism: the VADO study [J]. Parkinsonism Relat Disord, 2012, 18(6): 775-780.
|
| 27 |
Dunet V, Deverdun J, Charroud C, et al. MRI volumetric morphometry in vascular Parkinsonism [J]. J Neurol, 2017, 264(7): 1511-1519.
|
| 28 |
Jang W, Park J, Kim JS, et al. Triple stimulation technique findings in vascular Parkinsonism and Parkinson's disease [J]. Clin Neurophysiol, 2014, 125(9): 1834-1839.
|
| 29 |
Zijlmans JC, Daniel SE, Hughes AJ, et al. Clinicopathological investigation of vascular Parkinsonism，including clinical criteria for diagnosis [J]. Mov Disord, 2004, 19(6): 630-640.
|
| 30 |
Rektor I, Bohnen NI, Korczyn AD, et al. An updated diagnostic approach to subtype definition of vascular Parkinsonism-Recommendations from an expert working group [J]. Parkinsonism Related Disord, 2018, 49: 9-16.
|
| 31 |
Ling MJ, Aggarwal A, Morris JG. Dopa-responsive Parkinsonism secondary to right temporal lobe haemorrhage [J]. Mov Disord, 2002, 17(2): 402-404.
|
| 32 |
胡娟娟. 依达拉奉联合多巴丝肼片治疗血管性帕金森综合征的临床效果 [J]. 中国民康医学, 2019, 31(8): 26-27.
|
| 33 |
王琳琳. 丁苯酞联合美多芭治疗血管性帕金森综合征的临床效果观察 [J]. 中国现代药物应用, 2020, 14(1): 186-187.
|
| 34 |
翁国媚, 莫俊宁, 李又佳, 等. 单唾液酸四己糖神经节苷脂钠联合丁苯酞治疗血管性帕金森综合征患者的疗效及对认知功能的影响 [J]. 内科, 2020, 15(2): 195-196, 213.
|
| 35 |
Sato Y, Iwamoto J, Honda Y, et al. Vitamin D reduces falls and hip fractures in vascular Parkinsonism but not in Parkinson' sdisease [J]. Ther Clin Risk Manag, 2013, 9: 171-176.
|
| 36 |
余虹. 强化功能训练对血管性帕金森综合征运动功能的影响 [J]. 中国医学工程, 2019, 27(9): 47-50.
|
| 37 |
夏毅, 康冰, 杨宁, 等. 电针治疗血管性帕金森综合征22例 [J]. 中医杂志, 2011, 52(12): 1056-1057.
|
| 38 |
季庆玲, 周韦玮, 张向芝. 补肾活血熄风方治疗血管性帕金森综合征的临床效果分析 [J].中西医结合心血管病电子杂志, 2020, 8(9): 169.
|
| 39 |
许婉莹, 周世玲, 王麒颖. 熟地通络汤联合针刺对血管性帕金森综合征患者脑血流、认知功能、脑电功能的影响 [J]. 环球中医药, 2020, 13(11): 1890-1893.
|